ONCY

Oncolytics Biotech, Inc. Common Stock

ONCY
Closed
$0.88
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

The company is headquartered in Calgary, Alberta and currently employs 29 full-time employees.
Country

CA

CEO

Mr. Jared Kelly

IPO date

2001

Employees

28

ISIN

US68237V1035

Key stats

Open

$0.92

Volume

2.21M

Market cap

$158.59M

Prev. close

$0.92

Impl / hst vl

-

Open interest

$0.00

$0.87

Day’s Range

$0.94

$0.77

52W Range

$1.30

Valuation

22
Valuation score
Overvalued
P/E
-
P/S
-
P/B
26.37
Current ratio
2.88
Debt / Equity
-0.52
ROE
-440.39%
Gross margin
-
Income growth
-7.81%
FCF growth
-15.80

Analysts estimates

Consensus rating
Buy

The average rating from top 5 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$3.32
The top 5 analysts forecasts that 12-month price may increase by 277.20%, with a low of $2.55 and a high of $3.98
$2.55
Low
$3.32
Avg
$3.98
High
Current price

Earnings

Q2 ‘25 revenue
$0.00
Q2 ‘25 net income
-$6.17M
Revenue
Net income
Previous EPS
-
Estimate EPS
-$0.10
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply